Vaccines, Blood & Biologics
-
Section 8100: Communication
SOPP 8106: REVOKED: Submission of Product Approval Information For Dissemination to the Public
SOPP 8108: Currently under revision: Distribution of "Dear Doctor" Letters
-
8101: Meetings
SOPP 8101.1: Scheduling and Conduct of Regulatory Review Meetings with Sponsors and Applicants Effective Date: May 18, 2007 SOPP 8101.2: Scheduling and Documentation of Liaison Meetings Effective Date: November 17, 2000 SOPP 8101.3: Participation in or Planning of Outside Regulatory and Scientific Events Effective Date: August 3, 2005 SOPP 8103: Headquarters Contacts With Regulated Manufacturers During Agency Inspections Effective Date: April 9, 1999 SOPP 8104: Documentation of Telephone Contacts with Regulated Industry Effective Date: August 3, 2010 SOPP 8107: Official Correspondence with Applicants of Marketing Submissions: Addresses Effective Date: April 16, 2001 SOPP 8110: Submission of Paper Regulatory Applications to CBER Effective Date: June 3, 2010 SOPP 8113: Handling of Regulatory Faxes Effective Date: October 15, 2007 SOPP 8114: Administrative Processing of Documents Received Prior to Submitting Investigational or Marketing Applications (Pre-Application) Effective Date: April 16, 2007 SOPP 8115: Regulatory Site Visit Training Program Effective Date: November 22, 2005 SOPP 8116: Using Electronic Signatures for Investigational and Marketing Regulatory Document Concurrence/Signoff Effective Date: April 23, 2012 SOPP 8117: Issuing Submission Numbers in Advance of the Receipt of the Electronic Submission Effective Date: September 24, 2007 SOPP 8119: Use of Email for Regulatory Communications Effective Date: February 13, 2009
-
-
-